METTL3 depletion promotes STAT1 and IRF1 mRNA expression in an m6A-YTHDF2-dependent manner, which in turn improves immunotherapeutic response by modulation of tumor-infiltrating cells in the intratumor microenvironment of colorectal cancer [25]. This evidence concerns the gene IRF1 and colorectal cancer.